← Back to Search

Novel Eye Shield for Post-operative Eye Care

N/A
Recruiting
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over the course of the 2 cataract surgeries, approximately taking 3 months including preoperative and postoperative care.
Awards & highlights

Study Summary

This trial evaluates a novel eye shield to see if it can be used in post-surgery care to improve patient satisfaction and compliance.

Who is the study for?
This trial is for adult patients planning to have cataract surgery on both eyes within 3 months. It's not for pregnant individuals or those having more complex eye surgeries beyond standard cataract removal and lens placement.Check my eligibility
What is being tested?
The study compares a new type of eye shield with reusable adhesive anchors against the standard Alcon Eye Shield used after cataract surgery. Patients will try both shields, one after each eye's surgery, and share their preferences.See study design
What are the potential side effects?
Since this trial involves non-invasive protective eyewear rather than medication, traditional side effects are not applicable. However, discomfort or skin irritation from the adhesive might occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over the course of the 2 cataract surgeries, approximately taking 3 months including preoperative and postoperative care.
This trial's timeline: 3 weeks for screening, Varies for treatment, and over the course of the 2 cataract surgeries, approximately taking 3 months including preoperative and postoperative care. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of use of a new eye shield versus regular eye shield.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Novel prototype eye shield after surgeryExperimental Treatment1 Intervention
Novel prototype eye shield after surgery
Group II: Regular eye shield after surgeryActive Control1 Intervention
Alcon eye shield after surgery

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor
211 Previous Clinical Trials
85,048 Total Patients Enrolled

Media Library

Novel prototype eye shield after surgery Clinical Trial Eligibility Overview. Trial Name: NCT05957796 — N/A
Cataract Research Study Groups: Regular eye shield after surgery, Novel prototype eye shield after surgery
Cataract Clinical Trial 2023: Novel prototype eye shield after surgery Highlights & Side Effects. Trial Name: NCT05957796 — N/A
Novel prototype eye shield after surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05957796 — N/A
~10 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top